MedTrace Logo

Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia

NCT00565890 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-06-04

No results posted yet for this study

Summary

In order to determine the efficacy and safety of thyroxine replacement, a randomized clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the first month of age is conducted.

Conditions

  • Hypothyroxinemia

Interventions

DRUG

thyroxine

thyroxine at the dose of 5 μg/kg-wt /day

Sponsors & Collaborators

  • Tokyo Metropolitan Bokuto Hospital

    collaborator UNKNOWN

  • Tokyo Women's Medical University

    lead OTHER

Principal Investigators

  • Satoshi Kusuda, MD · Tokyo Women's Medical Unversity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Weeks
Max Age
4 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2011-03-31
Completion
2013-06-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00565890 on ClinicalTrials.gov